{"id":"NCT00039871","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)","officialTitle":"PEG-Intron Plus REBETOL for the Treatment of Subjects With Chronic Hepatitis C Who Failed to Respond to Previous Combination Therapy (Any Alpha Interferon Treatment in Combination With Ribavirin)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-05","primaryCompletion":"2007-09","completion":"2007-09","firstPosted":"2002-06-14","resultsPosted":"2008-12-11","lastUpdate":"2017-04-04"},"enrollment":2333,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis","Hepatitis C, Chronic","Fibrosis","Liver Cirrhosis"],"interventions":[{"type":"BIOLOGICAL","name":"PegIntron (peginterferon alfa-2b; SCH 54031)","otherNames":["SCH 54031"]},{"type":"DRUG","name":"REBETOL (ribavirin; SCH 18908)","otherNames":[]}],"arms":[{"label":"Overall study population","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to determine the effectiveness of PEG-Intron 1.5 ug/kg/wk plus REBETOL (ribavirin) 800-1400 mg/day in adults with chronic hepatitis C with moderate to severe liver fibrosis or cirrhosis who failed to respond to previous treatment with an alpha interferon in combination with ribavirin. Patients who do not respond to PEG-Intron plus REBETOL (ribavirin) will be enrolled in a long-term maintenance study to evaluate the effectiveness of PEG-Intron monotherapy versus no treatment for the prevention of disease progression (Protocols P02569 and P02570).","primaryOutcome":{"measure":"Sustained Virologic Response (SVR) Rate","timeFrame":"Assessed at end of 24 weeks posttreatment follow-up","effectByArm":[{"arm":"PegIntron Plus Rebetol","deltaMin":497,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21056496"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":200,"n":2312},"commonTop":["HEADACHE","PYREXIA","FATIGUE","MYALGIA","NAUSEA"]}}